CYCLERION THERAPEUTICS, INC. Preferred Stock, Shares Authorized
CYCLERION THERAPEUTICS, INC. (CYCN) had Preferred Stock, Shares Authorized of 100.00 million shares as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockSharesAuthorized · last filed 2026-08-04
- 2026-06-30: Preferred Stock, Shares Authorized 100.00M shares.
- 2026-03-31: Preferred Stock, Shares Authorized 100.00M shares.
- 2025-12-31: Preferred Stock, Shares Authorized 100.00M shares.
- 2025-09-30: Preferred Stock, Shares Authorized 100.00M shares.
| Period end | Preferred Stock, Shares Authorized | Preferred Stock, Shares Authorized as first filed |
|---|---|---|
| 2026-06-30 | 100.00M shares 10-Q · filed 2026-08-04 | |
| 2026-03-31 | 100.00M shares S-4/A · filed 2026-07-22 | |
| 2025-12-31 | 100.00M shares 10-Q · filed 2026-08-04 | |
| 2025-09-30 | 100.00M shares 10-Q · filed 2025-11-12 | |
| 2025-06-30 | 100.00M shares 10-Q · filed 2025-08-05 | |
| 2025-03-31 | 100.00M shares 10-Q · filed 2025-05-06 | |
| 2024-12-31 | 100.00M shares S-4/A · filed 2026-07-22 | |
| 2024-09-30 | 500.00K shares 10-Q · filed 2024-11-14 | |
| 2024-06-30 | 500.00K shares 10-Q · filed 2024-08-07 | |
| 2024-03-31 | 500.00K shares 10-Q · filed 2024-05-07 | |
| 2023-12-31 | 100.00M shares 10-K/A · filed 2025-11-12 | 500.00K shares 10-K · filed 2024-03-05 |
| 2023-09-30 | 500.00K shares 10-Q · filed 2023-11-13 | |
| 2023-06-30 | 500.00K shares 10-Q · filed 2023-07-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |